Hubei University of Chinese Medicine | China

Mr. Zhuowei Luo is an emerging researcher recognized for effectively integrating classical Traditional Chinese Medicine (TCM) theory with modern biomedical science, demonstrating strong expertise in molecular mechanism analysis and advanced metabolomics for chronic disease research. His notable scientific contribution is a co-authored publication in the Journal of Ethnopharmacology (Q2, IF 5.14), where he helped elucidate how Allium macrostemon delays chronic renal failure by modulating the IL-17 signaling pathway and altering tryptophan and glycerophospholipid metabolism. This work represents the first comprehensive study connecting immunological regulation with multi-omics profiling to explain the therapeutic mechanisms of this TCM herb, providing a meaningful model for modernizing traditional medicine through systems biology. His role in the project included designing and validating qPCR primers, conducting network pharmacology to identify key molecular targets, performing metabolomics and transcriptomics data analyses, and carrying out histopathological assessments. Through these contributions, he demonstrated an advanced ability to apply interdisciplinary approaches—combining immunology, pharmacology, and bioinformatics—to uncover mechanistic insights into natural product–based interventions. His research reflects scientific maturity beyond typical early-stage experience and contributes to the growing evidence supporting data-driven modernization of TCM in chronic disease treatment.

Profile : Orcid

Featured Publication

Zhao, Y., Ge, J. X., Zhang, N., Lei, Z. X., Sun, S. Y., Luo, Z. W., Yang, Y. F., & Wu, H. Z. (2025). Allium macrostemon Bge. delays chronic renal failure by modulating IL-17 signaling pathway and affecting tryptophan/glycerophospholipid metabolism. Journal of Ethnopharmacology, 120946.

Annalisa Bosi | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on 21/11/202521/11/2025 by Book of Award

Dr. Annalisa Bosi | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

University of Insubria | Italy

Dr. Annalisa Bosi is a distinguished researcher with 909 citations, 29 scientific documents, and an h-index of 15, reflecting her strong impact in the fields of immunology, gastrointestinal pathology, and microbiota–gut–brain axis research. Her early work focused on the phenotypic and functional characterization of innate immune components, particularly NK cells and macrophages, examining their role in tumor pathogenesis and their modulation by chemotherapeutic agents or plant-derived molecules. She later advanced her research to explore molecular and cellular mechanisms underlying major gastrointestinal diseases such as ischemia, intestinal inflammation, and enteric neuropathy, identifying the regulatory role of hyaluronic acid homeostasis in tissue repair. Her recent studies investigate gut microbiota, dysbiosis, and their influence on neurodevelopment and tumor etiopathogenesis, with growing emphasis on prebiotic and probiotic interventions. Dr. Bosi has contributed significantly to understanding experimental models of gut pathology, neuromuscular dysfunction, immunomodulation by virome components, and sex-dependent microbial effects. Her publications span high-impact journals, covering topics such as microbiota–immune interactions, ischemia–reperfusion injury, cytokine–phage crosstalk, and neuroimmune modulation. Through multidisciplinary approaches integrating molecular biology, immunology, and neurogastroenterology, her work continues to shape emerging perspectives on host–microbiota communication and its relevance to disease mechanisms and therapeutic strategies.

Profiles : Scopus | Orcid

Featured Publications

Bosi, A., Baranzini, N., Ponti, A., Moretto, P., Moro, E., Crema, F., Cianci, R., Karousou, E., Viola, M., Passi, A., et al. (2025). Intestinal ischemia/reperfusion injury influences hyaluronan homeostasis in the rat brain. International Journal of Molecular Sciences, 26(20), 10064.

Cianci, R., Caldarelli, M., Brani, P., Bosi, A., Ponti, A., Giaroni, C., & Baj, A. (2025). Cytokines meet phages: A revolutionary pathway to modulating immunity and microbial balance. Biomedicines, 13(5), 1202.

Faggin, S., Cerantola, S., Caputi, V., Tietto, A., Stocco, E., Bosi, A., Ponti, A., Bertazzo, A., Macchi, V., Porzionato, A., et al. (2025). Toll-like receptor 4 deficiency ameliorates experimental ileitis and enteric neuropathy: Involvement of nitrergic and 5-hydroxytryptaminergic neurotransmission. British Journal of Pharmacology, 182(8), 1803–1822.

Brani, P., Manzoor, H. Z., Spezia, P. G., Vigezzi, A., Ietto, G., Dalla Gasperina, D., Minosse, C., Bosi, A., Giaroni, C., Carcano, G., et al. (2025). Torque Teno Virus: Lights and shades. Viruses, 17(3), 334.

Dal Lago, S., Brani, P., Ietto, G., Dalla Gasperina, D., Gianfagna, F., Giaroni, C., Bosi, A., Drago Ferrante, F., Genoni, A., Manzoor, H. Z., et al. (2024). Torque Teno Virus: A promising biomarker in kidney transplant recipients. International Journal of Molecular Sciences, 25(14), 7744.

Giambra, V., Pagliari, D., Rio, P., Totti, B., Di Nunzio, C., Bosi, A., Giaroni, C., Gasbarrini, A., Gambassi, G., & Cianci, R. (2023). Gut microbiota, inflammatory bowel disease, and cancer: The role of guardians of innate immunity. Cells, 12(22), 2654.

Bosi, A., Banfi, D., Bistoletti, M., Catizzone, L. M., Chiaravalli, A. M., Moretto, P., Moro, E., Karousou, E., Viola, M., Giron, M. C., et al. (2022). Hyaluronan regulates neuronal and immune function in the rat small intestine and colonic microbiota after ischemic/reperfusion injury. Cells, 11(21), 3370.

Bosi, A., Banfi, D., Bistoletti, M., Moretto, P., Moro, E., Crema, F., Maggi, F., Karousou, E., Viola, M., Passi, A., et al. (2021). Hyaluronan: A neuroimmune modulator in the microbiota–gut axis. Cells, 11(1), 126.

Cerantola, S., Caputi, V., Contarini, G., Mereu, M., Bertazzo, A., Bosi, A., Banfi, D., Mantini, D., Giaroni, C., & Giron, M. C. (2021). Dopamine transporter genetic reduction induces morpho-functional changes in the enteric nervous system. Biomedicines, 9(5), 465.

Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021). Impact of microbial metabolites on microbiota–gut–brain axis in inflammatory bowel disease. International Journal of Molecular Sciences, 22(4), 1623.

Baci, D., Bosi, A., Parisi, L., Buono, G., Mortara, L., Ambrosio, G., & Bruno, A. (2020). Innate immunity effector cells as inflammatory drivers of cardiac fibrosis. International Journal of Molecular Sciences, 21(19), 7165.

Baci, D., Bosi, A., Gallazzi, M., Rizzi, M., Noonan, D. M., Poggi, A., Bruno, A., & Mortara, L. (2020). The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: A focus on innate immunity cells as therapeutic effectors. International Journal of Molecular Sciences, 21(9), 3125.

Bosi, A., Banfi, D., Bistoletti, M., Giaroni, C., & Baj, A. (2020). Tryptophan metabolites along the microbiota–gut–brain axis: An interkingdom communication system influencing the gut in health and disease. International Journal of Tryptophan Research, 13, 1–18.

Masroor Badshah | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on 29/08/202529/08/2025 by Book of Award

Dr. Masroor Badshah | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Monash University | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Dr. Masroor Badshah’s academic foundation is marked by a rigorous pursuit of medicine and anatomical sciences. Beginning with his degree in Medicine and Surgery, he developed an early research interest in the clinical relevance of anatomy, completing projects on skin diseases and vascular variations. His postgraduate studies at the University of Dundee expanded his expertise into human anatomy, where he defended a dissertation on carotid artery variations. This path led him to Monash University, where he earned his doctorate in medicine, focusing on oxytocin signaling in regulating the myogenic tone of the prostate and bladder. These early endeavors established a solid base for his later contributions to pharmacology and biomedical sciences.

Professional Endeavors

Dr. Badshah’s professional journey spans multiple countries, reflecting both versatility and international recognition. He began his teaching career as a lecturer and assistant professor in human anatomy at medical institutions in Pakistan before moving to Scotland and later Australia. His teaching associate roles at Monash University and research assistantship at the Monash Institute of Pharmaceutical Sciences allowed him to mentor students, design innovative teaching methodologies, and participate in collaborative research. His clinical internships in medicine and surgery also provided him with practical exposure that enriched his academic and research perspectives.

Contributions and Research Focus

At the core of Dr. Badshah’s career lies his dedication to advancing knowledge in pharmacology, toxicology, and pharmaceutical sciences. His doctoral work investigated the pharmacological role of oxytocin receptor antagonists in bladder and prostate function, with implications for overactive bladder treatments. His broader research includes studies in human surface anatomy, craniofacial asymmetry, morphometry of skeletal structures, and the clinical relevance of anatomical variations. By combining anatomical precision with pharmacological inquiry, he bridges the gap between foundational science and therapeutic application.

Accolades and Recognition

Throughout his career, Dr. Badshah has been honored with prestigious awards and scholarships, including the Monash Graduate Scholarship, Faculty International Tuition Scholarship, and the University of Dundee Tuition Scholarship. His academic excellence is reflected in multiple publications in peer-reviewed journals such as Biomedicines, Clinical Anatomy, and the Italian Journal of Anatomy and Embryology. He has also been a frequent presenter at international conferences, where his research findings on oxytocin signaling and anatomical morphometry have received recognition from the scientific community.

Impact and Influence

Dr. Badshah’s influence extends beyond research publications to shaping the next generation of medical and pharmaceutical scientists. His teaching philosophy emphasizes critical thinking, active participation, and evidence-based learning. By integrating innovative methodologies and fostering a collaborative learning environment, he has left a lasting impression on his students across different institutions. His work in surface anatomy and pharmacological sciences contributes to both clinical education and translational research, making his influence both academic and practical.

Legacy and Future Contributions

As a researcher with interdisciplinary expertise, Dr. Badshah’s legacy lies in his ability to merge anatomy with pharmacology for improved clinical outcomes. His ongoing research into bladder and prostate physiology offers potential breakthroughs in addressing urological disorders. Looking ahead, he aims to expand his collaborations globally, secure independent research leadership, and explore translational aspects of his work that could lead to therapeutic innovations. His legacy will continue to inspire young researchers and contribute to the evolution of biomedical sciences.

Publication

Investigating the Pharmacological Impact of Atosiban, an Oxytocin Receptor Antagonist, on Bladder and Prostate Contractions Within Obese and Non-Obese Rats
Authors: Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Sarah M. Turpin-Nolan, Khaled A. Elnahriry, Ralf Middendorff, Michael Whittaker, Betty Exintaris
Journal: Biomedicines
Year: 2025

Age-Dependent Effects of Oxytocin and Oxytocin Receptor Antagonists on Bladder Contractions: Implications for the Treatment of Overactive Bladder Syndrome
Authors: Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Ralf Middendorff, Michael Whittaker, Betty Exintaris
Journal: Biomedicines
Year: 2024

The Effects of Age on Prostatic Responses to Oxytocin and the Effects of Antagonists
Authors: Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Michael Whittaker, Betty Exintaris
Journal: Biomedicines
Year: 2023

Type of Treatment Supporters in Successful Completion of Tuberculosis Treatment: A Retrospective Cohort Study in Pakistan
Authors: Sana Hussain, Jamshed Hasnain, Zareen Hussain, Masroor Badshah, Hafeez Siddique, Christina Fiske, April Pettit
Journal: The Open Infectious Diseases Journal
Year: 2018

Morphology of the Human Hard Palate: A Study on Dry Skulls
Authors: Masroor Badshah, Roger Soames, Muhammad Jaffar Khan, Jamshaid Hasnain
Journal: Italian Journal of Anatomy and Embryology
Year: 2018

Conclusion

Dr. Masroor Badshah exemplifies the qualities of a dedicated academic, skilled researcher, and inspiring mentor. His career trajectory reflects a balance of teaching, research, and clinical exposure, with a focus on advancing pharmacology and anatomical sciences. His publications, conference presentations, and mentoring of students have strengthened his academic influence, while his research contributions offer practical applications in medicine. With a strong foundation and a vision for global collaboration, Dr. Badshah’s journey positions him as a leading figure in biomedical and pharmaceutical research, making his recognition as a distinguished researcher both timely and well-deserved.

Yuanyuan Li | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on 14/05/202514/05/2025 by Book of Award

Dr. Yuanyuan Li | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Guangdong Provincial Laboratory of Traditional Chinese Medicine | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Li’s academic path began with an exceptional undergraduate performance in Chemistry at Jilin University. Her passion for science led her to pursue a Master’s degree in Analytical Chemistry and subsequently a Ph.D. in the same field, which she completed in July 2014 under the guidance of esteemed professor Zhang Shusheng. During her doctoral studies, she received comprehensive training in analytical techniques and developed a strong interest in practical applications related to food and environmental safety.

Professional Endeavors

In 2014, Dr. Li joined the School of Public Health at Jilin University as a faculty member. She steadily rose through the ranks to become a full professor and doctoral supervisor. Her responsibilities have included leading multiple high-level national projects, mentoring graduate students, and engaging in collaborative research across disciplines. She has become a pivotal figure in shaping the academic direction of the university’s public health research programs.

Contributions and Research Focus

Dr. Li’s research primarily focuses on food safety risk assessment, monitoring of toxic and hazardous substances in the food chain, and the development of advanced analytical methods. She has published over 80 high-impact academic papers, including articles in Analytical Chemistry, Biosensors and Bioelectronics, ACS Sensors, and TrAC Trends in Analytical Chemistry. Her work integrates innovative electrochemical and optical biosensing techniques, making significant advancements in the detection of pesticide residues, foodborne pathogens, and environmental pollutants.

Accolades and Recognition

Her excellence has not gone unnoticed. Dr. Li has received several prestigious honors, including the “Young Elite Scientists Sponsorship Program” by the China Association for Science and Technology and the First Prize for Scientific and Technological Progress by the Jilin Provincial Government. She has also served as a visiting scholar at the University of Michigan, where she broadened her international research collaboration network.

Impact and Influence

Dr. Li's research has had a profound impact on public health, food regulation, and environmental policy. Her cutting-edge methodologies contribute directly to national standards and have been implemented in real-world food safety monitoring. She is also an active member of professional organizations and frequently serves as a reviewer for top-tier scientific journals, thereby shaping the future of analytical science and public health on both national and global scales.

Legacy and Future Contributions

Looking forward, Dr. Yuanyuan Li is poised to continue her groundbreaking work in biosensor development and integrated health risk assessment. Her vision is to establish more comprehensive detection platforms that can safeguard food and environmental quality, ultimately enhancing public health resilience. As a mentor, researcher, and innovator, her legacy is one of rigorous science combined with a deep commitment to societal well-being.

Publications

Shenxiong Yixin Decoction polysaccharides exert therapeutic effects against myocardial ischemia-reperfusion injury via intestinal exosomal microRNA-21 regulation

Authors:
De-Sheng Xu, Yan Wang, Zi-Rui Li, Ping-Li Mo, Ming-Tai Chen, Rui-Zhi Zhao, Zheng Fan, Wen-Jie Mo, Qi-Lu Li, Fang-Cao Pi, Qi-Di Sun, Juan-Min Li, Yun-Da Yao, Jian-Ping Chen, Yuan-Yuan Li, Jie-Nan Luan, Shang-Bin Zhang, Ying Xie, Hua Zhou

Journal: Pharmacological Research Year: 2025

Syringic acid attenuates acute lung injury by modulating macrophage polarization in LPS-induced mice

Authors:
W.-T. Wang, Y.-Y. Zhang, Z.-R. Li, J.-M. Li, H.-S. Deng, Y.-Y. Li, H.-Y. Yang, C.-C. Lau, Y.-J. Yao, H.-D. Pan, L. Liu, Y. Xie, H. Zhou et al.

Journal: Phytomedicine Year: 2024

A classical herbal formula alleviates high-fat diet induced nonalcoholic steatohepatitis (NASH) via targeting mitophagy to rehabilitate dysfunctional mitochondria, validated by UPLC-HRMS identification combined with in vivo experiment

Authors:
M.-T. Chen, F.R. Huang, B.-H. Chen, J.-L. Kang, Y.-J. Yao, M.-N. Liu, Y.-Y. Li, Y.-Q. Li, T.-R. Zhou, D.-T. Peng, L.-D. Luo, C.-S. Wei, Y.-F. Xing, Q.-B. Wu, H. Zhou, G.-D. Tong

Journal: Biomedicine & Pharmacotherapy Year: 2023

Simon Bernard Iloki Assanga | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on 17/02/202417/02/2024 by Book of Award

Prof Dr. Simon Bernard Iloki Assanga | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

University of Sonora | Mexico

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Dr. Simon Bernard Iloki Assanga embarked on his academic journey by obtaining a Bachelor's degree from the Pre-University Institute February 5 in Isle of Youth, Cuba, followed by a Graduate degree in Pharmaceutical Sciences from the University of Havana, Cuba. His academic pursuits culminated with a Doctorate in Pharmaceutical Sciences with a specialty in Immunology from the same institution in 2005.

Professional Endeavors

Dr. Assanga's professional career has been marked by a diverse array of roles, spanning from teaching to research. Noteworthy positions include his tenure as a Subject Teacher at the University of Sonora in Mexico, where he contributed to the Science department's Chemical-Biological sector. Additionally, he served as an Associate Full-Time Research Professor at the Department of Research and Postgraduate Studies in Food (DIPA) at the University of Sonora.

Contributions and Research Focus

Throughout his career, Dr. Assanga has made significant contributions to the field of pharmaceutical sciences and immunology. He has led various research projects, such as investigating the therapeutic potential of natural products for age-related macular degeneration and scaling up pilot plant production for nutraceuticals. His research interests also include exploring the chemical and nutritional composition of medicinal plants and their potential applications in healthcare.

Accolades and Recognition

Dr. Assanga's dedication and contributions have been recognized through numerous awards and honors. Notably, he received recognition for Outstanding Foreign Graduate from the Pharmacy Institute and Food at the University of Havana. He is also a member of prestigious scientific societies like the Society for Redox Biology and Medicine, highlighting his standing in the academic community.

Impact and Influence

Dr. Assanga's research, teaching, and participation in academic events have had a profound impact on the field of pharmaceutical sciences and immunology. His work in elucidating the therapeutic properties of natural products and mentoring students has contributed to advancements in healthcare and inspired future generations of researchers.

Legacy and Future Contributions

As a respected academic and researcher, Dr. Assanga's legacy lies in his extensive body of work, mentorship of aspiring scientists, and active participation in scientific discourse. His commitment to advancing knowledge in pharmaceutical sciences and immunology ensures that his contributions will continue to shape the field for years to come. In the future, he aims to further explore the therapeutic potential of natural products and collaborate on interdisciplinary research projects aimed at addressing pressing healthcare challenges.

Notable Publications

Nutraceuticals/Drugs Promoting Mitophagy and Mitochondrial Biogenesis May Combat the Mitochondrial Dysfunction Driving Progression of Dry Age-Related Macular Degeneration 2022 (10)

Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass 2022 (11)

Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity 2022 (20)

Assoc Prof Dr. Nicola Micale | Pharmacology, Toxicology and Pharmaceutical Science | Best Research Award

Published on 05/01/202405/01/2024 by Book of Award

Assoc Prof Dr. Nicola Micale | Pharmacology, Toxicology and Pharmaceutical Science | Best Research Award

University of Messina | Italy

Author Profile

Scopus

Early Academic Pursuits

Associate Professor Dr. Nicola Micale commenced his academic journey with an exceptional focus on Chemistry and Pharmaceutical Technology, culminating in an honored degree from the University of Messina. This foundation laid the groundwork for his specialization in pharmacology and pharmaceutical sciences.

Professional Endeavors

Micale's career trajectory has been marked by a series of esteemed positions, from pivotal research roles to impactful lectureships across Europe. His academic pursuits have extended globally, emphasizing collaborative research ventures and immersive academic experiences.

Contributions and Research Focus

Central to Micale's contributions is his intensive focus on neurodegenerative disorders and innovative drug design. His research spans diverse areas, ranging from peptidomimetics to targeted drug development, showcasing a commitment to combatting microbial infections and malignancies.

Accolades and Recognition

Micale's exemplary research earned him notable recognition, including the Farmindustria Award for Pharmaceutical Research and invitations to deliver lectures at prestigious international conferences. These accolades affirm his expertise and contributions to the field.

Impact and Influence

Beyond his research contributions, Micale's influence is evident through his pivotal roles on the editorial boards of multiple international scientific journals. His role as a reviewer for esteemed publications underscores his commitment to shaping scholarly dialogue and validating scientific research.

Legacy and Future Contributions

Associate Professor Dr. Nicola Micale's legacy is rooted in his multidisciplinary approach to pharmaceutical sciences and his dedication to fostering global scientific collaborations. His ongoing contributions are poised to drive advancements in pharmaceutical research, leaving a lasting imprint on the field's progression and innovation.

Notable Publications

Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 M pro 2023 (5)

Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 M pro Inhibitors 2023 (3)